News & Updates
Filter by Specialty:

Subgroup analyses boost masupirdine potential for AD
Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).
Subgroup analyses boost masupirdine potential for AD
15 Aug 2022
Depression, anxiety, sleep troubles common in primary Sjögren’s syndrome
Patients with primary Sjögren’s syndrome (pSS) show high levels of depression, anxiety, and sleep disturbances, reports a recent study. Cognitive impairments are also prevalent in this patient population.
Depression, anxiety, sleep troubles common in primary Sjögren’s syndrome
13 Aug 2022
Bilateral movement computer games improve upper limb recovery in stroke survivors
A randomized controlled trial conducted by researchers from Hong Kong Metropolitan University, the Hong Kong Polytechnic University and the Chinese University of Hong Kong found greater improvements in upper limb sensorimotor functions among subacute stroke survivors who engaged in bilateral movement-based computer games (BMCG) vs conventional rehabilitation (CR) alone.